2903 related articles for article (PubMed ID: 29415768)
21. Relevance of Minor Neuropsychological Deficits in Patients With Subjective Cognitive Decline.
Stark M; Wolfsgruber S; Kleineidam L; Frommann I; Altenstein S; Bartels C; Brosseron F; Buerger K; Burow L; Butryn M; Ewers M; Fliessbach K; Gabelin T; Glanz W; Goerss D; Gref D; Hansen N; Heneka MT; Hinderer P; Incesoy EI; Janowitz D; Kilimann I; Kimmich O; Laske C; Munk MH; Perneczky R; Peters O; Preis L; Priller J; Rauchmann BS; Rostamzadeh A; Roy-Kluth N; Sanzenbacher C; Schneider A; Schott BH; Spottke A; Spruth EJ; Teipel S; Vogt IR; Wiltfang J; Duzel E; Jessen F; Wagner M
Neurology; 2023 Nov; 101(21):e2185-e2196. PubMed ID: 37821235
[TBL] [Abstract][Full Text] [Related]
22. Cerebrospinal fluid synaptosomal-associated protein 25 is a key player in synaptic degeneration in mild cognitive impairment and Alzheimer's disease.
Zhang H; Therriault J; Kang MS; Ng KP; Pascoal TA; Rosa-Neto P; Gauthier S;
Alzheimers Res Ther; 2018 Aug; 10(1):80. PubMed ID: 30115118
[TBL] [Abstract][Full Text] [Related]
23. Association Between Later Life Lifestyle Factors and Alzheimer's Disease Biomarkers in Non-Demented Individuals: A Longitudinal Descriptive Cohort Study.
Reijs BLR; Vos SJB; Soininen H; Lötjonen J; Koikkalainen J; Pikkarainen M; Hall A; Vanninen R; Liu Y; Herukka SK; Freund-Levi Y; Frisoni GB; Frölich L; Nobili F; Rikkert MO; Spiru L; Tsolaki M; Wallin ÅK; Scheltens P; Verhey F; Visser PJ
J Alzheimers Dis; 2017; 60(4):1387-1395. PubMed ID: 29036813
[TBL] [Abstract][Full Text] [Related]
24. The combination of apolipoprotein E4, age and Alzheimer's Disease Assessment Scale - Cognitive Subscale improves the prediction of amyloid positron emission tomography status in clinically diagnosed mild cognitive impairment.
Ba M; Ng KP; Gao X; Kong M; Guan L; Yu L;
Eur J Neurol; 2019 May; 26(5):733-e53. PubMed ID: 30561868
[TBL] [Abstract][Full Text] [Related]
25. Memory Correlates of Alzheimer's Disease Cerebrospinal Fluid Markers: A Longitudinal Cohort Study.
Reijs BLR; Ramakers IHGB; Köhler S; Teunissen CE; Koel-Simmelink M; Nathan PJ; Tsolaki M; Wahlund LO; Waldemar G; Hausner L; Vandenberghe R; Johannsen P; Blackwell A; Vanderstichele H; Verhey F; Visser PJ
J Alzheimers Dis; 2017; 60(3):1119-1128. PubMed ID: 28984585
[TBL] [Abstract][Full Text] [Related]
26. Relation of Odor Identification with Alzheimer's Disease Markers in Cerebrospinal Fluid and Cognition.
Reijs BLR; Ramakers IHGB; Elias-Sonnenschein L; Teunissen CE; Koel-Simmelink M; Tsolaki M; Wahlund LO; Waldemar G; Hausner L; Johannsen P; Vanderstichele H; Verhey F; Devanand DP; Visser PJ
J Alzheimers Dis; 2017; 60(3):1025-1034. PubMed ID: 28984603
[TBL] [Abstract][Full Text] [Related]
27. Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease.
Mattsson N; Insel PS; Donohue M; Landau S; Jagust WJ; Shaw LM; Trojanowski JQ; Zetterberg H; Blennow K; Weiner MW;
Brain; 2015 Mar; 138(Pt 3):772-83. PubMed ID: 25541191
[TBL] [Abstract][Full Text] [Related]
28. Alzheimer Disease Signature Neurodegeneration and APOE Genotype in Mild Cognitive Impairment With Suspected Non-Alzheimer Disease Pathophysiology.
Schreiber S; Schreiber F; Lockhart SN; Horng A; Bejanin A; Landau SM; Jagust WJ;
JAMA Neurol; 2017 Jun; 74(6):650-659. PubMed ID: 28319241
[TBL] [Abstract][Full Text] [Related]
29. Predicting Imminent Progression to Clinically Significant Memory Decline Using Volumetric MRI and FDG PET.
Stonnington CM; Chen Y; Savage CR; Lee W; Bauer RJ; Sharieff S; Thiyyagura P; Alexander GE; Caselli RJ; Locke DEC; Reiman EM; Chen K
J Alzheimers Dis; 2018; 63(2):603-615. PubMed ID: 29630550
[TBL] [Abstract][Full Text] [Related]
30. Outcomes of stable and unstable patterns of subjective cognitive decline - results from the Leipzig Longitudinal Study of the Aged (LEILA75+).
Roehr S; Villringer A; Angermeyer MC; Luck T; Riedel-Heller SG
BMC Geriatr; 2016 Nov; 16(1):180. PubMed ID: 27814674
[TBL] [Abstract][Full Text] [Related]
31. Tau levels are higher in objective subtle cognitive decline but not subjective memory complaint.
Thomas KR; Weigand AJ; Edwards LC; Edmonds EC; Bangen KJ; Ortiz G; Walker KS; Bondi MW;
Alzheimers Res Ther; 2022 Aug; 14(1):114. PubMed ID: 35996158
[TBL] [Abstract][Full Text] [Related]
32. Tau plasma levels in subjective cognitive decline: Results from the DELCODE study.
Müller S; Preische O; Göpfert JC; Yañez VAC; Joos TO; Boecker H; Düzel E; Falkai P; Priller J; Buerger K; Catak C; Janowitz D; Heneka MT; Brosseron F; Nestor P; Peters O; Menne F; Schipke CG; Schneider A; Spottke A; Fließbach K; Kilimann I; Teipel S; Wagner M; Wiltfang J; Jessen F; Laske C
Sci Rep; 2017 Aug; 7(1):9529. PubMed ID: 28842559
[TBL] [Abstract][Full Text] [Related]
33. Alzheimer's Disease Biomarkers and Future Decline in Cognitive Normal Older Adults.
Dumurgier J; Hanseeuw BJ; Hatling FB; Judge KA; Schultz AP; Chhatwal JP; Blacker D; Sperling RA; Johnson KA; Hyman BT; Gómez-Isla T
J Alzheimers Dis; 2017; 60(4):1451-1459. PubMed ID: 29036824
[TBL] [Abstract][Full Text] [Related]
34. In Brief Neuropsychological Assessment, Amnestic Mild Cognitive Impairment (MCI) Is associated with Cerebrospinal Fluid Biomarkers for Cognitive Decline in Contrast to the Prevailing NIA-AA MCI Criterion.
Hessen E; Kirsebom BE; Eriksson CM; Eliassen CF; Nakling AE; Bråthen G; Waterloo KK; Aarsland D; Fladby T
J Alzheimers Dis; 2019; 67(2):715-723. PubMed ID: 30614807
[TBL] [Abstract][Full Text] [Related]
35. Prospective Evaluation of Cognitive Health and Related Factors in Elderly at Risk for Developing Alzheimer's Dementia: A Longitudinal Cohort Study.
Udeh-Momoh C; Price G; Ropacki MT; Ketter N; Andrews T; Arrighi HM; Brashear HR; Robb C; Bassil DT; Cohn M; Curry LK; Su B; Perera D; Giannakopoulou P; Car J; Ward HA; Perneczky R; Novak G; Middleton L
J Prev Alzheimers Dis; 2019; 6(4):256-266. PubMed ID: 31686098
[TBL] [Abstract][Full Text] [Related]
36. Cerebrospinal Fluid Biomarkers and Clinical Progression in Patients with Subjective Cognitive Decline and Mild Cognitive Impairment.
Wolfsgruber S; Polcher A; Koppara A; Kleineidam L; Frölich L; Peters O; Hüll M; Rüther E; Wiltfang J; Maier W; Kornhuber J; Lewczuk P; Jessen F; Wagner M
J Alzheimers Dis; 2017; 58(3):939-950. PubMed ID: 28527210
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic and Prognostic Value of the Combination of Two Measures of Verbal Memory in Mild Cognitive Impairment due to Alzheimer's Disease.
Sala I; Illán-Gala I; Alcolea D; Sánchez-Saudinós MB; Salgado SA; Morenas-Rodríguez E; Subirana A; Videla L; Clarimón J; Carmona-Iragui M; Ribosa-Nogué R; Blesa R; Fortea J; Lleó A
J Alzheimers Dis; 2017; 58(3):909-918. PubMed ID: 28527215
[TBL] [Abstract][Full Text] [Related]
38. Gender, apolipoprotein E genotype, and mesial temporal atrophy: 2-year follow-up in patients with stable mild cognitive impairment and with progression from mild cognitive impairment to Alzheimer's disease.
Spampinato MV; Langdon BR; Patrick KE; Parker RO; Collins H; Pravata' E;
Neuroradiology; 2016 Nov; 58(11):1143-1151. PubMed ID: 27590747
[TBL] [Abstract][Full Text] [Related]
39. CSF total tau levels are associated with hippocampal novelty irrespective of hippocampal volume.
Düzel E; Berron D; Schütze H; Cardenas-Blanco A; Metzger C; Betts M; Ziegler G; Chen Y; Dobisch L; Bittner D; Glanz W; Reuter M; Spottke A; Rudolph J; Brosseron F; Buerger K; Janowitz D; Fliessbach K; Heneka M; Laske C; Buchmann M; Nestor P; Peters O; Diesing D; Li S; Priller J; Spruth EJ; Altenstein S; Ramirez A; Schneider A; Kofler B; Speck O; Teipel S; Kilimann I; Dyrba M; Wiltfang J; Bartels C; Wolfsgruber S; Wagner M; Jessen F
Alzheimers Dement (Amst); 2018; 10():782-790. PubMed ID: 30555890
[TBL] [Abstract][Full Text] [Related]
40. Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia.
Frölich L; Peters O; Lewczuk P; Gruber O; Teipel SJ; Gertz HJ; Jahn H; Jessen F; Kurz A; Luckhaus C; Hüll M; Pantel J; Reischies FM; Schröder J; Wagner M; Rienhoff O; Wolf S; Bauer C; Schuchhardt J; Heuser I; Rüther E; Henn F; Maier W; Wiltfang J; Kornhuber J
Alzheimers Res Ther; 2017 Oct; 9(1):84. PubMed ID: 29017593
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
